Effects of Inflammatory Disease on Clinical Progression and Treatment of Ischiogluteal Bursitis: A Retrospective Observational Study
https://doi.org/10.5704/MOJ.2011.007
- Author:
Roh YH
1
;
Yoo SJ
1
;
Choi YH
1
;
Yang HC
1
;
Nam KW
1
Author Information
1. Department of Orthopaedics, Jeju National University Hospital, Jeju City, Republic of Korea
- Publication Type:Journal Article
- Keywords:
ischiogluteal bursitis, clinical course, inflammatory disease, treatment responsiveness, risk factor
- From:Malaysian Orthopaedic Journal
2020;14(No.3):32-41
- CountryMalaysia
- Language:English
-
Abstract:
Introduction: The symptoms of Ischiogluteal Bursitis (IGB)
are often nonspecific and atypical, and its diagnosis is more
challenging. Moreover, it is difficult to predict cases of
chronic progression or poor treatment response. Therefore,
the aim of this study was to investigate the clinical course of
IGB patients and identify factors that are predictive of failure
of conservative treatment.
Materials and Methods: Our study consisted of IGB
patients diagnosed between 2010 March and 2016 December
who had been followed-up for at least one year. Structured
questionnaires and medical records were reviewed to analyse
demographic characteristics, lifestyle patterns, blood tests,
and imaging studies. We categorized the cases into two
groups based on the response to conservative treatment and
the need for surgical intervention.
Results: The most common initial chief symptoms were
buttock pains in 24 patients (37.5%). Physical examinations
showed the tenderness of ischial tuberosity area in 59
(92.2%) patients, but no specific findings were confirmed in
5 patients (7.8%). 51 patients (79.7%) responded well to the
conservative management, 11 patients (17.2%) needed
injection, and 2 patients (3.1%) had surgical treatment
performed due to continuous recurrence. There was no
difference in demographic and blood lab data between the
two groups. However, the incidence of inflammatory
diseases (response group: 10.3% vs non-response group:
66.7%, p=0.004) was significantly different between the two
groups.
Conclusion: The diagnosis of IGB can be missed due to
variations in clinical symptoms, and cautions should be
exercised in patients with inflammatory diseases as
conservative treatment is less effective in them, leading to
chronic progression of IGB.
- Full text:16.2020my11081.pdf
